PDF
Word
Form 413 Morphine Milligram Equivalents (Mme) Cumulative Daily Override - Alabama
What Is Form 413?
This is a legal form that was released by the Alabama Medicaid Agency - a government authority operating within Alabama. As of today, no separate filing guidelines for the form are provided by the issuing department.
FAQ
Q: What is Form 413?
A: Form 413 is a document used in Alabama to calculate Morphine Milligram Equivalents (MME) for opioid prescriptions.
Q: What does MME stand for?
A: MME stands for Morphine Milligram Equivalents.
Q: What is the purpose of the MME?
A: The MME is used to standardize and compare the opioid dosages of different medications.
Q: What is the Cumulative Daily Override?
A: The Cumulative Daily Override is a field in Form 413 where a prescriber can document reasons for exceeding the recommended MME limit.
Q: How is the Cumulative Daily Override used?
A: The Cumulative Daily Override is used to justify higher opioid dosages when necessary for pain management.
Q: Why is the Cumulative Daily Override important?
A: The Cumulative Daily Override allows prescribers to ensure that patients with legitimate needs for higher opioid doses are not denied necessary medications.
Q: Is the Cumulative Daily Override required?
A: No, the Cumulative Daily Override is not required, but it is a helpful tool for prescribers.
Q: Who should use Form 413?
A: Form 413 should be used by prescribers in Alabama who are prescribing opioids.
Q: Is Form 413 specific to Alabama?
A: Yes, Form 413 is specific to Alabama and may not be used in other states.
Form Details:
- Released on August 3, 2022;
- The latest edition provided by the Alabama Medicaid Agency;
- Easy to use and ready to print;
- Quick to customize;
- Compatible with most PDF-viewing applications;
- Fill out the form in our online filing application.
Download a printable version of Form 413 by clicking the link below or browse more documents and templates provided by the Alabama Medicaid Agency.
